Long-Term Tolerability and Safety of HYQVIA/HyQvia in CIDP

Clinical trial NCT02955355 · COMPLETED

Trial details

NCT number: NCT02955355
Sponsor: Baxalta now part of Shire
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Start date: 2016-11-14
Primary completion: 2023-07-04
Enrollment: 85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.